Fatehalrahman Faris Magbool
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fatehalrahman Faris Magbool has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Abdrhman Mahmoud Gamil
Department of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Khartoum, Sudan
2 shared publicationsAsim Halfawi Shargi
Department of Pharmacognosy, Pharmacy Program Nile college Khartoum, Sudan
2 shared publicationsIbrahim Me
Al-Ribat National University, Khartoum, Sudan Faculty of Pharmacy Khartoum, Sudan
2 shared publicationsAbd Alsalam Sami
College of Pharmacy, Department of Pharmaceutical Analysis, Ribat National University, Sudan
1 shared publication- Abdulkadir Abdu
Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, 143005, India
1 shared publication - Ahed J Alkhatib
Department of Forensic Science and Toxicology, Faculty of Medicine, Jordan University of Science and Technology, Ar-Ramtha, Jordan
1 shared publication
Latest Publications
- 5 December 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 51
Efficacy of Novel Drug Delivery Systems for Insulin Administration and Technological Advances in Diabetes Mellitus: Review
Diabetes mellitus (DM) is a clinical syndrome characterized by disturbance in carbohydrate, fat and protein metabolism due to either insulin deficiency or
- 5 December 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 51
Efficacy of Novel Drug Delivery Systems for Insulin Administration and Technological Advances in Diabetes Mellitus: Review
Diabetes mellitus (DM) is a clinical syndrome characterized by disturbance in carbohydrate, fat and protein metabolism due to either insulin deficiency or
- Open Access
- 15 September 2025
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
COMPARATIVE STUDY OF THREE BRANDS OF SLIDENAFIL CITRATE TABLETS IN SUDANESE MARKETS
Aim and Objectives: This study assessed the quality of Sildenafil citrate tablet products, whether locally produced or imported, available in the Sudanese market, aiming to determine their potential interchangeability in clinical use. Methods: The quality evaluation of the drug products covered physical and organoleptic characteristics, along with tests for weight variation, friability, hardness, disintegration time, dissolution profile, and determination of Sildenafil content. The assay was performed using the standard HPLC method. Results: Findings indicated that the similarity between brand E & F was noticed in color, shape, film coat and weight, brand E, friability and hardness results were acceptable, the dissolution result showed that the peak release of the drug is between 30-45 minutes, disintegration of the tablet was not faster than brand F but shorter than brand S. Brands E and S were found to be containing more that the assumed concentration of Sildenafil Citrate (50 mg). Conclusion: The finding of this research clearly notes that the range of the active ingredient content in two brands out of the three is obviously way above limits. USP states that the tablet assay range flouts between 90-110%. Sildenafil is now widely prescribed for pulmonary hypertension in children here in Sudan, and it has been used with a high success ratio in this field, so the dosing system should be carefully measured, and without a proper Q.A, Q.C testing of the brands itself, it could lead to a very dangerous consequences. Peer Review History: Received 8 June 2025; Reviewed 11 July 2025; Accepted 20 August; Available online 15 September 2025 Academic Editor: Dr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com Reviewers: Aya Mohammed Mohammed Essawy, MTI University- Mokattam, Egypt, aya.essawy@gmail.com Dina Abd Elfattah Eldakhs, Pharos university (PUA), Egypt, dina_eldakhs@yahoo.com
- 15 September 2025
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
Open AccessCOMPARATIVE STUDY OF THREE BRANDS OF SLIDENAFIL CITRATE TABLETS IN SUDANESE MARKETS
Aim and Objectives: This study assessed the quality of Sildenafil citrate tablet products, whether locally produced or imported, available in the Sudanese market, aiming to determine their potential interchangeability in clinical use. Methods: The quality evaluation of the drug products covered physical and organoleptic characteristics, along with tests for weight variation, friability, hardness, disintegration time, dissolution profile, and determination of Sildenafil content. The assay was performed using the standard HPLC method. Results: Findings indicated that the similarity between brand E & F was noticed in color, shape, film coat and weight, brand E, friability and hardness results were acceptable, the dissolution result showed that the peak release of the drug is between 30-45 minutes, disintegration of the tablet was not faster than brand F but shorter than brand S. Brands E and S were found to be containing more that the assumed concentration of Sildenafil Citrate (50 mg). Conclusion: The finding of this research clearly notes that the range of the active ingredient content in two brands out of the three is obviously way above limits. USP states that the tablet assay range flouts between 90-110%. Sildenafil is now widely prescribed for pulmonary hypertension in children here in Sudan, and it has been used with a high success ratio in this field, so the dosing system should be carefully measured, and without a proper Q.A, Q.C testing of the brands itself, it could lead to a very dangerous consequences. Peer Review History: Received 8 June 2025; Reviewed 11 July 2025; Accepted 20 August; Available online 15 September 2025 Academic Editor: Dr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com Reviewers: Aya Mohammed Mohammed Essawy, MTI University- Mokattam, Egypt, aya.essawy@gmail.com Dina Abd Elfattah Eldakhs, Pharos university (PUA), Egypt, dina_eldakhs@yahoo.com
- Open Access
- 15 September 2025
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
FORMULATION AND EVALUATION OF TINIDAZOLE ENTERIC COATED TABLETS FOR COLON TARGETING DRUG DELIVERY SYSTEM
Aim and Objective: Colon-specific delivery systems have garnered significant attention for their capacity to localize therapy within the large intestine, thereby enhancing treatment efficacy for colonic disorders and reducing systemic toxicity. Methods: Core tablets containing tinidazole were prepared using a variety of polymers in distinct ratios, followed by application of an enteric coating. Pre-compression evaluation included assessment of powder flow characteristics and compatibility checks between the drug and excipients via FT-IR spectroscopy, with all batches demonstrating no evidence of interaction. Post-compression, tablets were tested for weight uniformity, mechanical strength, friability, and content uniformity, alongside in vitro dissolution studies under conditions simulating gastrointestinal transit. Results: All formulations exhibited acceptable chemical and physical properties, with assay values ranging from 98.44 % to 99.89 %, indicating consistent drug loading across batches F1 through F5. The F5 batch emerged as the optimal candidate, sustaining tinidazole release for six hours and achieving a cumulative release of 98.32 %. Stability testing of F5 at 45 °C and 75 % relative humidity over three months revealed no significant changes in performance or integrity. Consequently, formulation F5 is proposed as a robust platform for targeted colonic delivery of tinidazole. Conclusion: The investigation achieved the formulation of enteric-coated tinidazole tablets optimized for oral delivery and targeted release in the distal gastrointestinal tract. Peer Review History: Received 9 June 2025; Reviewed 14 July 2025; Accepted 23 August; Available online 15 September 2025 Academic Editor: Dr. DANIYAN Oluwatoyin Michael, Obafemi Awolowo University, ILE-IFE, Nigeria, toyinpharm@gmail.com Reviewers: Dr. Ali Awad Allah Ali Moh. Saeed, National University, Sudan, alimhsd@gmail.com Ali Jaber, Laboratory for Research and Development of Medicines and Natural Products, RDMPN, Faculty of Pharmacy, Lebanese University, Beirut, Lebanon, ali.jaber.2@ul.edu.lb
- 15 September 2025
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
Open AccessFORMULATION AND EVALUATION OF TINIDAZOLE ENTERIC COATED TABLETS FOR COLON TARGETING DRUG DELIVERY SYSTEM
Aim and Objective: Colon-specific delivery systems have garnered significant attention for their capacity to localize therapy within the large intestine, thereby enhancing treatment efficacy for colonic disorders and reducing systemic toxicity. Methods: Core tablets containing tinidazole were prepared using a variety of polymers in distinct ratios, followed by application of an enteric coating. Pre-compression evaluation included assessment of powder flow characteristics and compatibility checks between the drug and excipients via FT-IR spectroscopy, with all batches demonstrating no evidence of interaction. Post-compression, tablets were tested for weight uniformity, mechanical strength, friability, and content uniformity, alongside in vitro dissolution studies under conditions simulating gastrointestinal transit. Results: All formulations exhibited acceptable chemical and physical properties, with assay values ranging from 98.44 % to 99.89 %, indicating consistent drug loading across batches F1 through F5. The F5 batch emerged as the optimal candidate, sustaining tinidazole release for six hours and achieving a cumulative release of 98.32 %. Stability testing of F5 at 45 °C and 75 % relative humidity over three months revealed no significant changes in performance or integrity. Consequently, formulation F5 is proposed as a robust platform for targeted colonic delivery of tinidazole. Conclusion: The investigation achieved the formulation of enteric-coated tinidazole tablets optimized for oral delivery and targeted release in the distal gastrointestinal tract. Peer Review History: Received 9 June 2025; Reviewed 14 July 2025; Accepted 23 August; Available online 15 September 2025 Academic Editor: Dr. DANIYAN Oluwatoyin Michael, Obafemi Awolowo University, ILE-IFE, Nigeria, toyinpharm@gmail.com Reviewers: Dr. Ali Awad Allah Ali Moh. Saeed, National University, Sudan, alimhsd@gmail.com Ali Jaber, Laboratory for Research and Development of Medicines and Natural Products, RDMPN, Faculty of Pharmacy, Lebanese University, Beirut, Lebanon, ali.jaber.2@ul.edu.lb
- Open Access
- 30 June 2023
- Published by Maad Rayan Publishing Company in Journal of Biochemicals and Phytomedicine
- Vol. 2 (2) , 47-53
Evaluation of Phytochemical Properties and Antioxidant Activity of Methanol Extract of Ziziphus Spina-Christi, Satureja Khuzistanica, and Salvia Rosmarinus Using FT-IR Method
Introduction: Medicinal plants have shown special application in the pharmaceutical and food industries. Chemical analysis and determination of medicinal compounds of medicinal plants attract great attention throughout the world. The present study was designed to evaluate the phytochemical properties and antioxidant activity of methanol extract of three species of aromatic plants by FTIR method. Methods: Three species of aromatic plants including Konar (Ziziphus spina-christi), rosemary (Salvia rosmarinus), and Marzeh khuzestani (Satureja khuzistanica) were prepared and studied from the cities of Dehlran and Ilam locating in the west of Iran. These medicinal plants were dried and then powdered. The active groups of the medicinal plants were identified by the FT-IR method. Total antioxidant capacity was measured based on divalent iron reducing ability (FRAP) and by a single electron transfer mechanism. Results: The FT-IR results displayed that Z. spina-christi surrounds 11 functional groups, rosemary has 13 functional groups, and Khuzestani pepper contains 12 functional groups. The antioxidant potential of the methanolic extract of Z. spina-christi was 7 mmol Fe2+/L, rosemary was 1.93 mmol Fe2+/L, and Marzeh khuzestani was 12.99 mmol Fe2+/L. Conclusion: Ziziphus spina-christi, Salvia rosmarinus, and Satureja Khuzestani have strong antioxidant properties due to their chemical compounds and can be used for medicinal purposes.
- 30 June 2023
- Published by Maad Rayan Publishing Company in Journal of Biochemicals and Phytomedicine
- Vol. 2 (2) , 47-53
Open AccessEvaluation of Phytochemical Properties and Antioxidant Activity of Methanol Extract of Ziziphus Spina-Christi, Satureja Khuzistanica, and Salvia Rosmarinus Using FT-IR Method
Introduction: Medicinal plants have shown special application in the pharmaceutical and food industries. Chemical analysis and determination of medicinal compounds of medicinal plants attract great attention throughout the world. The present study was designed to evaluate the phytochemical properties and antioxidant activity of methanol extract of three species of aromatic plants by FTIR method. Methods: Three species of aromatic plants including Konar (Ziziphus spina-christi), rosemary (Salvia rosmarinus), and Marzeh khuzestani (Satureja khuzistanica) were prepared and studied from the cities of Dehlran and Ilam locating in the west of Iran. These medicinal plants were dried and then powdered. The active groups of the medicinal plants were identified by the FT-IR method. Total antioxidant capacity was measured based on divalent iron reducing ability (FRAP) and by a single electron transfer mechanism. Results: The FT-IR results displayed that Z. spina-christi surrounds 11 functional groups, rosemary has 13 functional groups, and Khuzestani pepper contains 12 functional groups. The antioxidant potential of the methanolic extract of Z. spina-christi was 7 mmol Fe2+/L, rosemary was 1.93 mmol Fe2+/L, and Marzeh khuzestani was 12.99 mmol Fe2+/L. Conclusion: Ziziphus spina-christi, Salvia rosmarinus, and Satureja Khuzestani have strong antioxidant properties due to their chemical compounds and can be used for medicinal purposes.
- Open Access
- 1 December 2022
- Published by CMV Verlag in Plant Biotechnology Persa
- Vol. 4 (2) , 1-11
Antihepatotoxic Effect of Eruca sativa Extracts on Alcohol Induced Liver Injury in Rats
- 1 December 2022
- Published by CMV Verlag in Plant Biotechnology Persa
- Vol. 4 (2) , 1-11
Open AccessAntihepatotoxic Effect of Eruca sativa Extracts on Alcohol Induced Liver Injury in Rats
- Open Access
- 15 March 2021
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
PHARMACEUTICAL EVALUATION AND POST-MARKET SURVEILLANCE STUDY OF THREE BRANDS OF LISINOPRIL TABLETS IN SUDAN
Background: Lisinopril is a type of angiotensin-converting enzyme (ACE) inhibitor that used to treat high blood pressure (hypertension) in adults and children. The safety and efficacy of drug products can be assured when their quality is consistent and reproducible. To ensure the requisite quality, pharmaceutical companies are required to test their products during and after manufacturing and at various intervals during the shelf life of the product. Methods: The aim of this study was to study and evaluate the physicochemical and pharmaceutical parameters in order to confirm the pharmaceutical quality of the generic Lisinopril tablet formulations available in Sudan. Evaluation was done based on the compendia physicochemical and pharmaceutical evaluation parameters. Different brands of Lisinopril 5mg tablets purchased randomly from drug stores, and coded Z, L and A, were assayed for weight uniformity, friability, hardness, disintegration, dissolution rate using standard physical methods, and also the similarity is studied to compare brand of originator to the generic products. Their percentage drug contents were determined using standard UV Spectrophotometric method. Results: All the brands being studied comply the pharmacopoeial specifications for weight uniformity, friability, disintegration and dissolution. The dissolution profile shows more than 80 % release in 30 minutes. Additionally, all brands should similarity factor above 50% and therefore to be consider as similar. Quantitatively, all the three brands being tested do complied with the pharmacopoeial specifications for drug content. Conclusion: Hence this study will serve as a tool in assessing the pharmaceutical quality and to monitor post market quality, safety and efficacy of Lisinopril tablet formulations. Peer Review History: Received 18 January 2021; Revised 13 February; Accepted 3 March, Available online 15 March 2021 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file: Reviewer's Comments: Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Prof. Dr. A. Hakan AKTAŞ, Süleyman Demirel University, Faculty of Science and Art, Department of Chemistry, Isparta-Turkey, hakanaktas@sdu.edu.tr Dr. Vijay Kumar Singh, Institute of Pharmacy, Bundelkhand University, Jhansi, India, vijayquantum@gmail.com Dr. Hayriye Eda Şatana Kara, Gazi University, Turkey, eda@gazi.edu.tr Similar Articles: QUALITY ASSESSMENT OF DIFFERENT BRANDS OF PARACETAMOL TABLETS IN YEMENI MARKET QUALITY CONTROL ASSESSMENT OF DIFFERENT BRANDS OF CIPROFLOXACIN 500 MG TABLETS IN YEMEN
- 15 March 2021
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
Open AccessPHARMACEUTICAL EVALUATION AND POST-MARKET SURVEILLANCE STUDY OF THREE BRANDS OF LISINOPRIL TABLETS IN SUDAN
Background: Lisinopril is a type of angiotensin-converting enzyme (ACE) inhibitor that used to treat high blood pressure (hypertension) in adults and children. The safety and efficacy of drug products can be assured when their quality is consistent and reproducible. To ensure the requisite quality, pharmaceutical companies are required to test their products during and after manufacturing and at various intervals during the shelf life of the product. Methods: The aim of this study was to study and evaluate the physicochemical and pharmaceutical parameters in order to confirm the pharmaceutical quality of the generic Lisinopril tablet formulations available in Sudan. Evaluation was done based on the compendia physicochemical and pharmaceutical evaluation parameters. Different brands of Lisinopril 5mg tablets purchased randomly from drug stores, and coded Z, L and A, were assayed for weight uniformity, friability, hardness, disintegration, dissolution rate using standard physical methods, and also the similarity is studied to compare brand of originator to the generic products. Their percentage drug contents were determined using standard UV Spectrophotometric method. Results: All the brands being studied comply the pharmacopoeial specifications for weight uniformity, friability, disintegration and dissolution. The dissolution profile shows more than 80 % release in 30 minutes. Additionally, all brands should similarity factor above 50% and therefore to be consider as similar. Quantitatively, all the three brands being tested do complied with the pharmacopoeial specifications for drug content. Conclusion: Hence this study will serve as a tool in assessing the pharmaceutical quality and to monitor post market quality, safety and efficacy of Lisinopril tablet formulations. Peer Review History: Received 18 January 2021; Revised 13 February; Accepted 3 March, Available online 15 March 2021 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file: Reviewer's Comments: Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Prof. Dr. A. Hakan AKTAŞ, Süleyman Demirel University, Faculty of Science and Art, Department of Chemistry, Isparta-Turkey, hakanaktas@sdu.edu.tr Dr. Vijay Kumar Singh, Institute of Pharmacy, Bundelkhand University, Jhansi, India, vijayquantum@gmail.com Dr. Hayriye Eda Şatana Kara, Gazi University, Turkey, eda@gazi.edu.tr Similar Articles: QUALITY ASSESSMENT OF DIFFERENT BRANDS OF PARACETAMOL TABLETS IN YEMENI MARKET QUALITY CONTROL ASSESSMENT OF DIFFERENT BRANDS OF CIPROFLOXACIN 500 MG TABLETS IN YEMEN
- Open Access
- 15 May 2020
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
IMPROVED HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/MASS SPECTROSCOPY (HPLC/MS) METHOD FOR DETECTION OF ANTHRAQUINONES AND ANTIOXIDANT POTENTIAL DETERMINATION IN ALOE SINKATANA
Objectives: Medicinal plants, either as an extract, pure compound or as a derivative, offer limitless opportunities for the discovery of new drugs. Sudan is a very rich source of medicinal plants which are used in the treatment of a wide range of diseases. Aloe sinkatana, has great potential to be developed as drug by pharmaceutical industries. The present study is undertaken to investigate the antioxidant potential of Aloe sinkatana by DPPH radical scavenging activity. In addition, the study also performed to explore the possibility of using HPLC-MS technique for the determination and analysis of Aloe sinkatana. Methods: The extracts of Aloe sinkatana were analyzed for antioxidant activity by using DPPH free radical scavenging activity. The results indicated that the extracts showed a high effective free radical scavenging in the DPPH assay, also these extracts exhibited a noticeable antioxidant effect at low concentrations. Results: During in vitro evaluation the antioxidant potential of methanolic extract was the highest, followed by aqueous extract in DPPH radical scavenging activity. So the methanolic extract of the plant, exhibited a great antioxidant effect at 50 μg/ml which may be attributed to high phenolic content. Therefore, methanolic extract to be a more active radical scavenger than aqueous extract. The HPLC-MS analysis had shown the methanolic extract of Aloe sinkatana to be rich in the major anthraquinones and their glucosides, which revealed 9 compounds, and also UV spectroscopy detected the presence of two flavonoids. Conclusion: The results indicated that the extracts of Aloe sinkatana is a potential source of natural antioxidants or nutraceuticals with potential application to reduce oxidative stress with consequent health benefits. Due to stronger antioxidant potential and phytochemical composition, Aloe sinkatana could be proved as a valuable prospect in pharmaceutical formulations by taking part in the antioxidant defense system against generation of free radicals. Peer Review History: Received 26 March 2019; Revised 15 April; Accepted 4 May, Available online 15 May 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 4.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Prof Cyprian Ogbonna ONYEJI Affiliation: Obafemi Awolowo University, Ile-Ife, Nigeria E-mail: conyeji@oauife.edu.ng Name: Dr. Gehan Fawzy Abdel Raoof Kandeel Affiliation: Pharmacognosy Department, National Research Centre, Dokki, 12622, Giza, Egypt E-mail: gehankandeel9@yahoo.com Name: Dr. Nyunaï Nyemb Affiliation: Ministry of Scientific Research and Innovation of Cameroon E-mail: nyunain@yahoo.fr Comments of reviewer(s): Similar Articles: ANTIHYPERGLYCEMIC AND ANTI-OXIDANT POTENTIAL OF ETHANOL EXTRACT OF VITEX THYRSIFLORA LEAVES ON DIABETIC RATS
- 15 May 2020
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
Open AccessIMPROVED HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/MASS SPECTROSCOPY (HPLC/MS) METHOD FOR DETECTION OF ANTHRAQUINONES AND ANTIOXIDANT POTENTIAL DETERMINATION IN ALOE SINKATANA
Objectives: Medicinal plants, either as an extract, pure compound or as a derivative, offer limitless opportunities for the discovery of new drugs. Sudan is a very rich source of medicinal plants which are used in the treatment of a wide range of diseases. Aloe sinkatana, has great potential to be developed as drug by pharmaceutical industries. The present study is undertaken to investigate the antioxidant potential of Aloe sinkatana by DPPH radical scavenging activity. In addition, the study also performed to explore the possibility of using HPLC-MS technique for the determination and analysis of Aloe sinkatana. Methods: The extracts of Aloe sinkatana were analyzed for antioxidant activity by using DPPH free radical scavenging activity. The results indicated that the extracts showed a high effective free radical scavenging in the DPPH assay, also these extracts exhibited a noticeable antioxidant effect at low concentrations. Results: During in vitro evaluation the antioxidant potential of methanolic extract was the highest, followed by aqueous extract in DPPH radical scavenging activity. So the methanolic extract of the plant, exhibited a great antioxidant effect at 50 μg/ml which may be attributed to high phenolic content. Therefore, methanolic extract to be a more active radical scavenger than aqueous extract. The HPLC-MS analysis had shown the methanolic extract of Aloe sinkatana to be rich in the major anthraquinones and their glucosides, which revealed 9 compounds, and also UV spectroscopy detected the presence of two flavonoids. Conclusion: The results indicated that the extracts of Aloe sinkatana is a potential source of natural antioxidants or nutraceuticals with potential application to reduce oxidative stress with consequent health benefits. Due to stronger antioxidant potential and phytochemical composition, Aloe sinkatana could be proved as a valuable prospect in pharmaceutical formulations by taking part in the antioxidant defense system against generation of free radicals. Peer Review History: Received 26 March 2019; Revised 15 April; Accepted 4 May, Available online 15 May 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 4.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Prof Cyprian Ogbonna ONYEJI Affiliation: Obafemi Awolowo University, Ile-Ife, Nigeria E-mail: conyeji@oauife.edu.ng Name: Dr. Gehan Fawzy Abdel Raoof Kandeel Affiliation: Pharmacognosy Department, National Research Centre, Dokki, 12622, Giza, Egypt E-mail: gehankandeel9@yahoo.com Name: Dr. Nyunaï Nyemb Affiliation: Ministry of Scientific Research and Innovation of Cameroon E-mail: nyunain@yahoo.fr Comments of reviewer(s): Similar Articles: ANTIHYPERGLYCEMIC AND ANTI-OXIDANT POTENTIAL OF ETHANOL EXTRACT OF VITEX THYRSIFLORA LEAVES ON DIABETIC RATS
- Open Access
- 8 March 2020
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
IN VITRO-IN VIVO BIO-EQUIVALENCE CORRELATION STUDY OF METRONIDAZOLE, AND ITS BRANDS OF IMMEDIATE RELEASE TABLET UNDER BIO-WAIVER CONDITIONS
Objective: The aim of present study is to examine the in-vitro in-vivo correlation (IVIVC) of immediate release product. Metronidazole 500mg and its brands of immediate release dosage forms. Metronidazole is clearly classified into BCS class I, and could be evaluated under bio waiver conditions. Methods: The in vitro parameters employed were hardness, weight uniformity, friability, disintegration time, absolute drug content, dissolution rate (in 0.1 N Hydrochloric acid, phosphate buffer and acetate buffer at 37ºC), and dissolution efficiencies were also analyzed. The in-vitro dissolution study was performed on the brands, according to FDA,USP dissolution profile in three different PH (1.2), (4.5), and (6.8) at37ºC, using the USP apparatus II, then f1, f2 were determined for the time intervals of 10, 15, 30, 45 and 60 minutes, and dissolution efficiencies were calculated. MINITAB 14 statistical program used for in vitro in vivo correlation, level A was done for reference product. Results: A non linear relation was established which is typical for immediate release formulation, of class 1. There was significant relationship between in vitro and in vivo data of reference metronidazole product, Correlation and distribution of data with correlation coefficient (r=0.724, 0.837, 0.707), nonlinear relationship with p-value (>0.05) =(0.167, 0.098, 0.182), there is no out lines, no lake of fits at P-Values=0.0040, 006, 0.026. Conclusion: Study concluded that there is no linear correlation between percent of drug released and percent of drug absorbed ,this may be due to uncontrollable gastric emptying rate for class one Metronidazole. Peer Review History: Received 2 January 2020; Revised 1 February; Accepted 3 March, Available online 15 March 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 4.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Dr. Hayriye Eda Şatana Kara Affiliation: Gazi University, Turkey E-mail: eda@gazi.edu.tr Name: Dr. Mohamed Ismail Nounou Affiliation: Appalachian College of Pharmacy, Oakwood, Virginia, USA E-mail: nounou@acp.edu Comments of reviewer(s): Similar Articles: IN VITRO-IN VIVO BIO-EQUIVALENCE CORRELATION STUDY OF ATENOLOL, AND ITS BRANDS OF IMMEDIATE RELEASE TABLET UNDER BIO-WAIVER CONDITIONS
- 8 March 2020
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
Open AccessIN VITRO-IN VIVO BIO-EQUIVALENCE CORRELATION STUDY OF METRONIDAZOLE, AND ITS BRANDS OF IMMEDIATE RELEASE TABLET UNDER BIO-WAIVER CONDITIONS
Objective: The aim of present study is to examine the in-vitro in-vivo correlation (IVIVC) of immediate release product. Metronidazole 500mg and its brands of immediate release dosage forms. Metronidazole is clearly classified into BCS class I, and could be evaluated under bio waiver conditions. Methods: The in vitro parameters employed were hardness, weight uniformity, friability, disintegration time, absolute drug content, dissolution rate (in 0.1 N Hydrochloric acid, phosphate buffer and acetate buffer at 37ºC), and dissolution efficiencies were also analyzed. The in-vitro dissolution study was performed on the brands, according to FDA,USP dissolution profile in three different PH (1.2), (4.5), and (6.8) at37ºC, using the USP apparatus II, then f1, f2 were determined for the time intervals of 10, 15, 30, 45 and 60 minutes, and dissolution efficiencies were calculated. MINITAB 14 statistical program used for in vitro in vivo correlation, level A was done for reference product. Results: A non linear relation was established which is typical for immediate release formulation, of class 1. There was significant relationship between in vitro and in vivo data of reference metronidazole product, Correlation and distribution of data with correlation coefficient (r=0.724, 0.837, 0.707), nonlinear relationship with p-value (>0.05) =(0.167, 0.098, 0.182), there is no out lines, no lake of fits at P-Values=0.0040, 006, 0.026. Conclusion: Study concluded that there is no linear correlation between percent of drug released and percent of drug absorbed ,this may be due to uncontrollable gastric emptying rate for class one Metronidazole. Peer Review History: Received 2 January 2020; Revised 1 February; Accepted 3 March, Available online 15 March 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 4.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Dr. Hayriye Eda Şatana Kara Affiliation: Gazi University, Turkey E-mail: eda@gazi.edu.tr Name: Dr. Mohamed Ismail Nounou Affiliation: Appalachian College of Pharmacy, Oakwood, Virginia, USA E-mail: nounou@acp.edu Comments of reviewer(s): Similar Articles: IN VITRO-IN VIVO BIO-EQUIVALENCE CORRELATION STUDY OF ATENOLOL, AND ITS BRANDS OF IMMEDIATE RELEASE TABLET UNDER BIO-WAIVER CONDITIONS
- Open Access
- 15 January 2020
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
IN VITRO-IN VIVO BIO-EQUIVALENCE CORRELATION STUDY OF ATENOLOL, AND ITS BRANDS OF IMMEDIATE RELEASE TABLET UNDER BIO-WAIVER CONDITIONS
The aim of present study is to examine the in-vitro-in-vivo correlation (IVIVC) of immediate release product. Atenolol 100mg and its brands of immediate release dosage forms. Atenolol is clearly classified into BCS class III, and could be evaluated under bio waiver conditions. The in vitro parameters employed were hardness, weight uniformity, friability, disintegration time, absolute drug content, dissolution rate (in 0.1 N Hydrochloric acid, phosphate buffer and acetate buffer at 37ºC), and dissolution efficiencies were also analyzed. The in-vitro dissolution study was performed on the brands, according to FDA,USP dissolution profile in three different PH (1.2),(4.5), and (6.8) at 37ºC, using the USP apparatus II, then f1, f2 were determined for the time intervals of 10, 15, 30, 45 and 60 minutes, and dissolution efficiencies were calculated. MINITAB 14 statistical program used for in vitro-in vivo correlation, level A was done for reference product. A non linear relation was established which is typical for immediate release formulation, of class III. Peer Review History: UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 3.0/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Dr. Hayriye Eda Şatana Kara Affiliation: Gazi University, Turkey E-mail: eda@gazi.edu.tr Name: Dr. Nicola Micale Affiliation: University of Messina, Italy E-mail: nmicale@unime.it Comments of reviewer(s): Similar Articles: FAST DISSOLVING DRUG DELIVERY SYSTEMS: FORMULATION, PREPARATION TECHNIQUES AND EVALUATION FAST DISSOLVING TABLETS: A PROMISING APPROACH FOR DRUG DELIVERY DEVELOPMENT AND EVALUATION OF FAST DISSOLVING THIN FILMS OF ARIPIPRAZOLE TABLET GRANULATION: CURRENT SCENARIO AND RECENT ADVANCES
- 15 January 2020
- Published by Society of Pharmaceutical Tecnocrats in Universal Journal of Pharmaceutical Research
Open AccessIN VITRO-IN VIVO BIO-EQUIVALENCE CORRELATION STUDY OF ATENOLOL, AND ITS BRANDS OF IMMEDIATE RELEASE TABLET UNDER BIO-WAIVER CONDITIONS
The aim of present study is to examine the in-vitro-in-vivo correlation (IVIVC) of immediate release product. Atenolol 100mg and its brands of immediate release dosage forms. Atenolol is clearly classified into BCS class III, and could be evaluated under bio waiver conditions. The in vitro parameters employed were hardness, weight uniformity, friability, disintegration time, absolute drug content, dissolution rate (in 0.1 N Hydrochloric acid, phosphate buffer and acetate buffer at 37ºC), and dissolution efficiencies were also analyzed. The in-vitro dissolution study was performed on the brands, according to FDA,USP dissolution profile in three different PH (1.2),(4.5), and (6.8) at 37ºC, using the USP apparatus II, then f1, f2 were determined for the time intervals of 10, 15, 30, 45 and 60 minutes, and dissolution efficiencies were calculated. MINITAB 14 statistical program used for in vitro-in vivo correlation, level A was done for reference product. A non linear relation was established which is typical for immediate release formulation, of class III. Peer Review History: UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 3.0/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Dr. Hayriye Eda Şatana Kara Affiliation: Gazi University, Turkey E-mail: eda@gazi.edu.tr Name: Dr. Nicola Micale Affiliation: University of Messina, Italy E-mail: nmicale@unime.it Comments of reviewer(s): Similar Articles: FAST DISSOLVING DRUG DELIVERY SYSTEMS: FORMULATION, PREPARATION TECHNIQUES AND EVALUATION FAST DISSOLVING TABLETS: A PROMISING APPROACH FOR DRUG DELIVERY DEVELOPMENT AND EVALUATION OF FAST DISSOLVING THIN FILMS OF ARIPIPRAZOLE TABLET GRANULATION: CURRENT SCENARIO AND RECENT ADVANCES